Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 6, 2006, Pages 743-748

  Ruiz Moreno, José M ^a,b   Montero, Javier A ^b   Arias, Luis ^c   Sanabria, Maria R ^d   Coco, Rosa ^e   Silva, Rufino ^f   Araiz, Javier ^g   Gomez Ulla, Francisco ^h   Garcia Layana, Alfredo ⁱ  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b VISSUM Corporacion Oftalmologica   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^e UNIVERSITY OF VALLADOLID   (Spain)

^f UNIVERSITY OF COIMBRA   (Portugal)

^g UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^h UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

ⁱ UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Choroidal neovascularization; Idiopathic neovascularization; Inflammatory neovascularization; Photodynamic therapy

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; ARTICLE; BIOMICROSCOPY; CASE STUDY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; MALE; MULTICENTER STUDY; OPHTHALMOSCOPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA FOVEA; SLIT LAMP; STUDENT T TEST; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 33750619222     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00691.x     Document Type: Article

References (22)

1. Adelberg DA, Del Priore LV & Kaplan HJ (1995): Surgery for subfoveal membranes in myopia, angioid streaks and other disorders. Retina 15: 198-205.
2. Bressler SB, Bressler NM, Fine SL, Hillis A, Murphy RP, Olk RJ & Patz A (1982): Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. Am J Ophthalmol 93: 157-163.
3. Busquets MA, Shah GK, Wickens J et.al. (2003): Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Retina 23: 299-306.
4. Chan WM, Lam DSC, Wong TK, Lai TY, Kwok AK, Tam BS & Li KK (2003): Photodynamic therapy for subfoveal idiopathic choroidal neovascularization. Ophthalmology 110: 2395-2402.
5. Danis RP, Ciulla TA, Pratt LM & Anliker W (2000): Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20: 244-250.
6. Flaxel CJ, Owens SL, Mulholland B, Schwartz SD & Gregor ZJ (1998): The use of corticosteroids for choroidal neovascularization in young patients. Eye 12: 266-272.
7. Hart PM, Chakravarthy U, Mackenzie G et.al. (2002): Visual outcomes in the subfoveal radiotherapy study: A randomized controlled trial of teletherapy for age-related macular degeneration. Arch Ophthalmol 120: 1029-1238.
8. Leslie T, Lois N, Christopoulou D, Olson JA & Forrester JV (2005): Photodynamic therapy for inflammatory choroidal neovascularization unresponsive to immunosuppression. Br J Ophthalmol 89: 147-150.
9. Liu JC, Boldt HC, Folk JC & Gehrs KM (2004): Photodynamic therapy of subfoveal and juxtafoveal choroidal neovascularization in ocular histoplasmosis syndrome. Retina 24: 863-870.
10. Rogers AH, Duker JS, Nichols N & Baker BJ (2003): Photodynamic therapy of idiopathic inflammatory choroidal neovascularization in young adults. Ophthalmology 110: 1315-1320.
11. Shah GK, Blinder KJ, Hariprasad SM, Thomas MA, Ryan EH Jr, Bakal J & Sharma S (2005): Photodynamic therapy for juxtafoveal choroidal neovascularization due to ocular histoplasmosis syndrome. Retina 25: 26-32.
12. Sickenberg M (2000): A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks and idiopathic causes. Arch Ophthalmol 118: 327-336.
13. Spaide RF, Freund KB, Slakter J, Sorenson J, Yannuzzi LA & Fisher Y (2002b): Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina 22: 545-549.
14. Spaide RF, Martin ML, Slakter J, Yannuzzi LA, Sorenson J, Guyer DR & Freund KB (2002a): Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol 134: 62-68.
15. Spaide RF, Sorenson J & Maranan L (2003): Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110: 1517-1525.
16. Spaide RF, Sorenson J & Maranan L (2005): Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112: 301-304.
17. Thomas MA, Dickinson JD, Melberg NS, Ibanez HE & Dhaliwal RS (1994): Visual results after surgical removal of subfoveal choroidal neovascularization. Ophthalmology 101: 1384-1396.
18. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999): Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin (1-year results of two randomized clinical trials). TAP Report 1. Arch Ophthalmol 117: 1329-1345.
19. Verteporfin in Photodynamic Therapy (VIP) Study Group (2001a): Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization. VIP Report 2. Am J Ophthalmol 131: 541-560.
20. Verteporfin in Photodynamic Therapy (VIP) Study Group (2001b): Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial. VIP Report 1. Ophthalmology 108: 841-852.
21. Wachtlin J, Heimann H, Behme T & Foerster MH (2003): Longterm results after photodynamic therapy with verteporfin for choroidal neovascularization secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol 241: 899-906.
22. Wachtlin J, Wehner A, Heimann H & Foerster MH (2004): Photodynamic treatment with verteporfin for patients with idiopathic choroidal neovascularization. Two-year results. Ophthalmologe 101: 489-495.